Dai­ichi Sankyo launch­es glob­al R&D re­struc­tur­ing, look­ing to slash costs in an over­haul

You can add Japan’s Dai­ichi Sankyo to the list of phar­ma com­pa­nies re­struc­tur­ing their R&D or­ga­ni­za­tions.

Like Take­da be­fore it and a whole line­up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.